IP Library › Granted Patent US 12,234,488
Granted Patent B2
US 12,234,488 · App. 18/068,739 · Granted Feb 25, 2025

Mutant reverse transcriptase with increased thermal stability as well as products, methods and uses involving the same

Inventors: Christian Helmut Bell (Basel, CH); Harald Sobek (Biberach, DE); Heiko Walch (Munich, DE); Kiyoshi Yasukawa (Koyoto, JP); Misato Baba (Hyto, JP)
Assignee: Roche Diagnostics Operations, Inc.
C12N9/1276C12P19/34C12Q1/68C12Y207/07049
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,234,488
App. No.
18/068,739
Granted
Feb 25, 2025
Kind
B2
Abstract

The present invention relates to a mutant reverse transcriptase (RT) with increased thermal stability relative to the wildtype, a nucleic acid encoding the mutant RT, a cell comprising the mutant RT or the nucleic acid, a kit comprising the mutant RT, the use of the mutant RT for cDNA synthesis, method for reverse transcription of RNA comprising synthesizing cDNA with the use of the mutant RT and a method for detecting an RNA marker in a sample with the use of the mutant RT.

Claims (12)

1. A method for reverse transcription of a mRNA, the method comprising synthesizing a cDNA from the mRNA using a mutant reverse transcriptase (RT), the mutant RT consisting of

i) an amino acid sequence that has only six amino acid substitutions of SEQ ID NO: 1, wherein, in SEQ ID NO:1,

Ala at position 32 is substituted with Val (A32V);

Leu at position 72 is substituted with Arg (L72R);

Glu at position 286 is substituted with Arg (E286R);

Glu at position 302 is substituted with Lys (E302K);

Trp at position 388 is substituted with Arg (W388R); and

Leu at position 435 is substituted with Arg (L435R),

wherein the mutant RT exhibits a reverse transcriptase activity, and wherein the mutant RT also has an increased thermal stability relative to a mutant MM3, wherein the mutant MM3 has an amino acid sequence that differs from the amino acid sequence of SEQ ID NO: 1 and only has three amino acid substitutions of SEQ ID NO: 1, wherein, in SEQ ID NO:1, Glu at position 286 is substituted with Arg (E286R), Glu at position 302 is substituted with Lys (E302K) and Leu at position 435 is substituted with Arg (L435R).

2. The method of claim 1 , wherein the reverse transcriptase activity of the mutant RT is at least 50% of the reverse transcriptase activity of the wildtype RT.

3. The method of claim 1 , wherein the mutant RT is capable of fusing to another protein.

4. The method of claim 1 , wherein the mutant RT consists of SEQ ID NO:2.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2022
From: YASUKAWA, KYOSHI; BABA, MISATO
To: KYOTO UNIVERSITY
Reel/Frame 062187/0977 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2022
From: KYOTO UNIVERSITY
To: GMBH, ROCHE DIAGNOSTICS
Reel/Frame 062188/0054 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2022
From: BELL, CHRISTIAN HELMUT; SOBEK, HERALD; WALCH, HEIKO
To: GMBH, ROCHE DIAGNOSTICS
Reel/Frame 062188/0190 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2022
From: ROCHE DIAGNOSTICS GMBH
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 062188/0288 →
Priority Claims (1)
EP 17000621 · Apr 11, 2017 · regional
Continuity (3)
Division 16599407 · Oct 11, 2019
Continuation PCTEP2018059170 · Apr 10, 2018
Related Publication 20230203460A1 · Jun 29, 2023
References Cited (22)
US 8530218B2 · Ferrari et al. · 2013 [cited by applicant]
US 9663770B2 · Rogers et al. · 2017 [cited by applicant]
US 10184009B2 · Ast et al. · 2019 [cited by applicant]
CN 1430670A · 2003 [cited by applicant]
CN 102414321A · 2012 [cited by applicant]
CN 106164261A · 2016 [cited by applicant]
WO WO01092500A1 · 2001 [cited by applicant]
WO 2009125006A2 · 2009 [cited by applicant]
WO 2015075842A1 · 2015 [cited by applicant]
Arezi et al., Novel mutations in Moloney Murine Leukemia Virus reverse transcriptase increase thermostability through tighter binding to template-primer; Nucleic Acids Research, 2009, vol. 37, No. 2, pp. 473-481. [cited by applicant]
Baranauskas et al., Generation and characterization of new highly thermostable and processive M-MuLV reverse transcriptase variants; Protein Engineering, Design & Selection, 2012, vol. 25, No. 10, pp. 657-668. [cited by applicant]
Bradford Marion M., A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding; Analytical Biochemistry, 1976, vol. 72, pp. 248-254. [cited by applicant]
Gerard et al., The role of template-primer in protection of reverse transcriptase from thermal inactivation; Nucleic Acids Research; 2002, vol. 30, No. 14, pp. 3118-3129. [cited by applicant]
Kotewicz et al., Cloning and overexpression of Moloney murine leukemia virus reverse transcriptase in [cited by applicant]
Ma et al., Effects of various emulsification methods on the oxidation of methyl linoleate; Bioscience, Biotechnology, and Biochemistry, 2014, vol. 78, No. 1, pp. 147-150. [cited by applicant]
Mizuno et al., Insight into the Mechanism of th Stabililzation of Moloney Murine Leukaemia Virus Reverse Transcriptase by Eliminating RNase H Activity; Biosci. Biotechmol. Biochem., 2010, vol. 74, No. 2, pp. 440-442. [cited by applicant]
Shoichet et al., A relationship between protein stability and protein function; Proc. Natl. Acad. Sci., 1995, vol. 92, pp. 452-465. [cited by applicant]
Yasukawa et al., Increase in thermal stability of Moloney murine leukemia virus reverse transcriptase by site-directred mutagenesis; Journal of Biotechnology, 2010, vol. 150, pp. 299-306. [cited by applicant]
Baba et al., Further increase in thermostability of Moloney murine leukemia virus reverse transcriptase by mutational combination, Protein Engineering, Design and Selection, 30, 551-557, 2017. [cited by applicant]
Database Geneseq BCA51017, “MMLV reverse transcriptase mutant protein E286R/E302K/L435R,” Jul. 16, 2015. [cited by applicant]
Cao et al., 2015, Progress in Mucopolysaccharidoses Research, Journal of Qiqihar University of Medicine, 25: 16-23. [cited by applicant]
Zhu et al., 2015, Analysis of MLC1 gene mutation in a Chinese family with megalen-cephalic eukoencephalopathy with subcortical cysts Chinese Journal of Contemporary Pediatrics, 04: 78-84. [cited by applicant]